Spruce Biosciences Inc. (SPRB) Fundamentals

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
SHARE INFORMATION
Market Cap$ 45,576,174
Shares Outstanding23,492,873
Float17,284,063
Percent Float73.57%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.80
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions122
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months341,965
Institutional Holdings Percent100.7%
Institutional Sold Previous 3 Months1,970,387
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months221,071
Insider Holdings Percent0.0
Insider Sold Previous 3 Months50,468
Insider Shares Owned5,862
TRADING INFO
52 Week High$ 8.59
52 Week Low$ 1.25
52 Week High Change$ -76.02
21 Day Moving Average$ 1.9338
21 Day Extended Moving Average$ 1.9154
50 Day Moving Average$ 1.7846
50 Day Extended Moving Average$ 1.8449
200 Day Moving Average$ 2.4474
200 Day Extended Moving Average$ 3.447
10 Day Average Volume26,678
20 Day Average Volume29,786
30 Day Average Volume33,523
50 Day Average Volume169,569
Alpha-0.103827
Beta1.6201
Standard Deviation0.249120
R20.114270
7 Day Price Change$ 0.13
7 Day Percent Change7.18%
21 Day Price Change$ -0.02
21 Day Percent Change-1.02%
30 Day Price Change$ 0.04
30 Day Percent Change2.11%
Month to Date Price Change$ 0.09
Month to Date Percent Change4.86%
Quarter to Date Price Change$ 0.20
Quarter to Date Percent Change11.49%
180 Day Price Change$ -0.38
180 Day Percent Change-16.38%
200 Day Price Change$ -0.64
200 Day Percent Change-24.81%
Year to Date Price Change$ -2.52
Year to Date Percent Change-56.5%

Spruce Biosciences Inc. (SPRB) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity0.10
Int Coverage-127.80
Current Ratio10.60
Leverage Ratio1.10
Quick Ratio10.20
Long Term Debt To Capital0.05
VALUATION MEASURES
PE Ratio-1.10
Enterprise Value$ -36,261,753
Price to Sales0.00
Price to Free Cash-1.70
PE High Last 5 Years0.00
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-32.84
Return on Equity-36.66
Return on Capital-34.49

Spruce Biosciences Inc. (SPRB) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorBDO USA, LLP
CEOJavier Szwarcberg
Emplyoees16
Last AuditUQ
CIK0001683553
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address2001 Junipero Serra Boulevard
Suite 640
Daly City, CA 94014
Websitehttps://www.sprucebiosciences.com
Facsimile-
Telephone+1 415 655-4168
Emailinvestors@sprucebiosciences.com
Your Recent History
NASDAQ
SPRB
Spruce Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220810 23:02:13